Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics

Por Bertino, Joseph S
Publicado em 2009

Annual Review of Pharmacology

Por Bertino, Joseph R.
Publicado em 1967

Alan Sartorelli: A Personal Remembrance

Por Bertino, Joseph R.
Publicado no Oncologist (2015)

Impaired utilization of serum folate in pernicious anemia: A study with radiolabeled 5-methyltetrahydrofolate

Por Nixon, Peter F., Bertino, Joseph R.
Publicado em 1972

Treatment of leukemia with large doses of methotrexate and folinic acid: clinical-biochemical correlates

Por Hryniuk, William M., Bertino, Joseph R.
Publicado em 1969

MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine

Por Mishra, Prasun J, Bertino, Joseph R
Publicado em 2009

Simplified Estimation of Aminoglycoside Pharmacokinetics in Underweight and Obese Adult Patients

Por Pai, Manjunath P., Nafziger, Anne N., Bertino, Joseph S.
Publicado em 2011

6-Thioguanine: A Drug With Unrealized Potential for Cancer Therapy

Por Munshi, Pashna N., Lubin, Martin, Bertino, Joseph R.
Publicado em 2014

Overexpression of the Mitochondrial Folate and Glycine–Serine Pathway: A New Determinant of Methotrexate Selectivity in Tumors

Por Vazquez, Alexei, Tedeschi, Philip M., Bertino, Joseph R.
Publicado em 2012

Intestinal Folate Absorption: II. CONVERSION AND RETENTION OF PTEROYLMONOGLUTAMATE BY JEJUNUM

Por Olinger, Edward J., Bertino, Joseph R., Binder, Henry J.
Publicado em 1973

Intestinal folate absorption: I. 5-Methyltetrahydrofolic acid

Por Strum, Williamson, Nixon, Peter F., Bertino, Joseph B., Binder, Henry J.
Publicado em 1971

Targeting tumors that lack methylthioadenosine phosphorylase (MTAP) activity: Current strategies

Por Bertino, Joseph R, Waud, William R, Parker, William B, Lubin, Martin
Publicado em 2011

Mitochondrial Methylene Tetrahydrofolate Dehydrogenase (MTHFD2) Overexpression is Associated with Tumor Cell Proliferation and is a Novel Target for Drug Development

Por Tedeschi, Philip M., Vazquez, Alexei, Kerrigan, John E., Bertino, Joseph R.
Publicado no Mol Cancer Res (2015)

MTHFD2- a new twist?

Por Tedeschi, Philip M., Scotto, Kathleen W., Kerrigan, John, Bertino, Joseph R.
Publicado no Oncotarget (2016)

Optimizing Aminoglycoside Therapy for Nosocomial Pneumonia Caused by Gram-Negative Bacteria

Por Kashuba, Angela D. M., Nafziger, Anne N., Drusano, George L., Bertino, Joseph S.
Publicado em 1999

Authors' response: Poor correlation between 6β-hydroxycortisol:cortisol molar ratios and midazolam clearance as measure of hepatic CYP3A activity: a comment

Por Chen, Ya-Chi, Nafziger, Anne N, Bertino, Joseph S, Kashuba, Angela D M
Publicado em 2007

Evaluation of Dose-Intense Ifosfamide, with and Without Edatrexate, in Adults with Sarcoma

Por Casper, Ephraim S., Schwartz, Gary M., Leung, Denis, Sugarman, Alison, Bertino, Joseph R.
Publicado em 1999

Leucovorin rescue allows effective high-dose pralatrexate treatment and an increase in therapeutic index in mesothelioma xenografts

Por Tedeschi, Philip M., Kathari, Yamini K., Farooqi, Iqra N., Bertino, Joseph R.
Publicado em 2014

Methylthioadenosine phosphorylase (MTAP)-deficient T-cell ALL xenografts are sensitive to pralatrexate and 6-thioguanine alone and in combination

Por Tedeschi, Philip M., Kathari, Yamini K., Johnson-Farley, Nadine, Bertino, Joseph R.
Publicado no Cancer Chemother Pharmacol (2015)

Maribavir Pharmacokinetics and the Effects of Multiple-Dose Maribavir on Cytochrome P450 (CYP) 1A2, CYP 2C9, CYP 2C19, CYP 2D6, CYP 3A, N-Acetyltransferase-2, and Xanthine Oxidase...

Por Ma, Joseph D., Nafziger, Anne N., Villano, Stephen A., Gaedigk, Andrea, Bertino, Joseph S.
Publicado em 2006